Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB04920
http://purl.obolibrary.org/obo/dinto_DB04920
|
|---|---|
| Preferred Name | clevidipine |
| Synonyms |
methyl 5-{[(butanoyloxy)methoxy]carbonyl}-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate
C21H23Cl2NO6
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | clevidipine
|
|---|---|
| label | clevidipine
|
| DBSynonym | clevidipine butyrate
|
| Definition | Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.
|
| induces | |
| inhibits | |
| type | |
| InChIKey | InChIKey=KPBZROQVTHLCDU-UHFFFAOYSA-N
|
| is metabolised by | |
| Synonym | methyl 5-{[(butanoyloxy)methoxy]carbonyl}-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate
C21H23Cl2NO6
|
| xref |
National Drug Code Directory:65293-005-50
Wikipedia:http://en.wikipedia.org/wiki/Clevidipine
|
| CASRN | 166432-28-6
|
| prefixIRI | obo2:dinto_DB04920
|
| related with | |
| SMILES | CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
|
| may interact with | |
| InChI | InChI=1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3
|
| DBBrand | cleviprex
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |